Physiological Effect: Reversed Anticoagulation Activity
Drugs with Physiological Effect: Reversed Anticoagulation Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orbicular | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 216298-001 | Mar 13, 2026 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sciegen Pharms | PHYTONADIONE | phytonadione | TABLET;ORAL | 213329-001 | Jul 28, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 216601-001 | Nov 4, 2025 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
